if this actually prevents expensive knee replacements, the ROI for insurers should be a no-brainer. the challenge is the high monthly cost vs long-term surgery savings it's hard to model when people switch carriers every few years and take the health benefit with them.
In theory, yes, but until these medications become generic, it will continue to cause huge losses for insurance companies. The cost of these medicines alone is worth more than premiums